fr 66973 has been researched along with cytarabine in 1 studies
| Studies (fr 66973) | Trials (fr 66973) | Recent Studies (post-2010) (fr 66973) | Studies (cytarabine) | Trials (cytarabine) | Recent Studies (post-2010) (cytarabine) |
|---|---|---|---|---|---|
| 18 | 1 | 1 | 15,487 | 2,424 | 3,188 |
| Protein | Taxonomy | fr 66973 (IC50) | cytarabine (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 7.533 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manda, T; Masuda, K; Matsumoto, S; Mori, J; Nakamura, T; Oku, T; Shimomura, K | 1 |
1 other study(ies) available for fr 66973 and cytarabine
| Article | Year |
|---|---|
Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Division; Cytarabine; DNA, Neoplasm; Flow Cytometry; Leukemia L1210; Mitomycin; Mitomycins; Mitosis; Oxazines; Time Factors; Vinblastine | 1989 |